In CML, EVI1 overexpression has been associated with the higher self-renewal capacity of CML stem cells and resistance to tyrosine kinase inhibitors in murine models [11]. The gene discussed is MECOM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.